← FDA Drug Approvals (Drugs@FDA)
BYETTA
NDA · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2005-04-28
Drug application
- FDA Application #
NDA021773- Application type
- New Drug Application
- Brand name
- BYETTA
- Generic name
- EXENATIDE
- Active ingredients
- EXENATIDE SYNTHETIC
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- ASTRAZENECA AB
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2005-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown